NCT03556228 2025-12-11VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaVM Oncology, LLCPhase 1/2 Recruiting242 enrolled
NCT05107674 2025-09-09A Study of NX-1607 in Adults With Advanced MalignanciesNurix Therapeutics, Inc.Phase 1 Recruiting345 enrolled